PTC Therapeutics Inc. (PTCT)
42.56
0.75 (1.79%)
At close: Jan 15, 2025, 1:44 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Net Income | -626.60M | -559.02M | -523.90M | -438.16M | -251.58M | -128.08M | -79.00M | -142.11M | -170.45M | -93.75M | -51.57M | -26.24M | 30.90M |
| Depreciation & Amortization | 236.59M | 128.84M | 64.13M | 84.87M | 32.18M | 26.09M | 17.68M | 3.29M | 2.88M | 2.23M | 2.40M | 2.70M | 2.87M |
| Stock-Based Compensation | 131.21M | 110.33M | 103.51M | 70.33M | 42.13M | 33.25M | 30.56M | 35.01M | 33.98M | 19.31M | 8.43M | 2.29M | 2.82M |
| Other Working Capital | -42.63M | -57.74M | -4.01M | -8.03M | -1.39M | 6.51M | 7.87M | 727.00K | -3.40M | 2.40M | -5.20B | -25.13M | -57.31M |
| Other Non-Cash Items | 151.32M | 82.81M | 128.33M | 46.11M | 49.37M | 27.38M | 7.27M | 9.41M | 2.25M | 21.05M | 6.05M | 225.73K | 416.61K |
| Deferred Income Tax | -46.93M | -34.28M | 377.00K | 5.87M | 8.83M | -490.00K | 199.00K | -199.00K | 2.30M | -19.31M | 92.46K | -1.78M | -461.95K |
| Change in Working Capital | -4.00M | -85.33M | -23.79M | 36.91M | 20.43M | 14.21M | 13.23M | -8.96M | 4.70M | 13.20M | -12.31M | -25.13M | -57.31M |
| Operating Cash Flow | -158.42M | -356.65M | -251.33M | -194.07M | -98.64M | -27.64M | -10.06M | -103.57M | -124.34M | -57.27M | -46.92M | -47.93M | -20.77M |
| Capital Expenditures | -120.62M | -152.46M | -85.33M | -55.98M | -45.44M | -15.53M | -3.10M | -1.78M | -2.72M | -4.66M | -845.73K | -188.68K | -165.12K |
| Acquisitions | n/a | 128.44M | 57.12M | 38.13M | -4.00M | -48.89M | -77.16M | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -212.48M | -75.55M | -543.27M | -1.45B | -494.07M | -68.61M | -81.37M | -85.38M | -223.76M | -247.80M | -156.04M | n/a | -2.02M |
| Sales Maturities Of Investments | 156.37M | 518.19M | 847.78M | 944.09M | 156.27M | 90.42M | 174.75M | 191.63M | 205.67M | 107.30M | 29.06M | n/a | 29.89M |
| Other Investing Acitivies | -92.18M | -128.44M | -57.12M | -38.13M | -373.48M | 13.38M | 16.22M | 106.26M | -18.09M | -140.50M | -126.98M | n/a | n/a |
| Investing Cash Flow | -176.74M | 290.18M | 219.18M | -561.55M | -387.24M | -42.61M | 13.12M | 104.48M | -20.81M | -145.17M | -127.83M | -188.68K | 27.70M |
| Debt Repayment | -301.38M | 148.72M | -2.22M | -46.16M | 267.60M | n/a | 40.00M | n/a | 150.00M | -49.00K | -5.00M | -6.94M | -7.19M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 947.78M | -30.77M | 23.10M | 686.78M | 21.85M | 13.65M | 4.22M | 968.00K | 4.06M | 1.20M | 60.79M | 29.36M | n/a |
| Financial Cash Flow | 646.40M | 167.95M | 20.88M | 668.72M | 613.21M | 131.57M | 44.22M | 968.00K | 154.06M | 237.13M | 187.44M | 22.41M | -7.18M |
| Net Cash Flow | 314.36M | 98.71M | -19.09M | -79.22M | 126.03M | 57.71M | 53.47M | 299.00K | 8.27M | 34.33M | 12.69M | -25.71M | -243.46K |
| Free Cash Flow | -279.04M | -509.11M | -336.66M | -250.05M | -144.08M | -43.17M | -13.16M | -105.34M | -127.06M | -61.94M | -47.77M | -48.12M | -20.93M |